Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
27.70
+2.21 (8.67%)
At close: Dec 5, 2025, 4:00 PM EST
27.60
-0.10 (-0.36%)
After-hours: Dec 5, 2025, 7:59 PM EST

Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of $10.82 billion. The enterprise value is $4.91 billion.

Market Cap 10.82B
Enterprise Value 4.91B

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

Moderna has 390.73 million shares outstanding. The number of shares has increased by 1.31% in one year.

Current Share Class 390.73M
Shares Outstanding 390.73M
Shares Change (YoY) +1.31%
Shares Change (QoQ) +0.52%
Owned by Insiders (%) 6.52%
Owned by Institutions (%) 71.84%
Float 364.94M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.81
Forward PS 5.70
PB Ratio 1.16
P/TBV Ratio 1.17
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.20
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.08.

Current Ratio 3.93
Quick Ratio 3.51
Debt / Equity 0.08
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -432.88

Financial Efficiency

Return on equity (ROE) is -29.32% and return on invested capital (ROIC) is -18.54%.

Return on Equity (ROE) -29.32%
Return on Assets (ROA) -15.49%
Return on Invested Capital (ROIC) -18.54%
Return on Capital Employed (ROCE) -33.13%
Revenue Per Employee $384,828
Profits Per Employee -$537,241
Employee Count 5,800
Asset Turnover 0.16
Inventory Turnover 12.46

Taxes

Income Tax -37.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -33.46% in the last 52 weeks. The beta is 1.11, so Moderna's price volatility has been higher than the market average.

Beta (5Y) 1.11
52-Week Price Change -33.46%
50-Day Moving Average 25.86
200-Day Moving Average 27.66
Relative Strength Index (RSI) 60.59
Average Volume (20 Days) 9,893,738

Short Selling Information

The latest short interest is 64.36 million, so 16.47% of the outstanding shares have been sold short.

Short Interest 64.36M
Short Previous Month 63.66M
Short % of Shares Out 16.47%
Short % of Float 17.63%
Short Ratio (days to cover) 5.55

Income Statement

In the last 12 months, Moderna had revenue of $2.23 billion and -$3.12 billion in losses. Loss per share was -$8.05.

Revenue 2.23B
Gross Profit -2.40B
Operating Income -3.46B
Pretax Income -3.15B
Net Income -3.12B
EBITDA -3.26B
EBIT -3.46B
Loss Per Share -$8.05
Full Income Statement

Balance Sheet

The company has $4.50 billion in cash and $734.00 million in debt, giving a net cash position of $5.91 billion or $15.13 per share.

Cash & Cash Equivalents 4.50B
Total Debt 734.00M
Net Cash 5.91B
Net Cash Per Share $15.13
Equity (Book Value) 9.33B
Book Value Per Share 23.86
Working Capital 4.92B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.98 billion and capital expenditures -$675.00 million, giving a free cash flow of -$2.65 billion.

Operating Cash Flow -1.98B
Capital Expenditures -675.00M
Free Cash Flow -2.65B
FCF Per Share -$6.79
Full Cash Flow Statement

Margins

Gross margin is -107.62%, with operating and profit margins of -155.15% and -139.61%.

Gross Margin -107.62%
Operating Margin -155.15%
Pretax Margin -141.26%
Profit Margin -139.61%
EBITDA Margin -145.83%
EBIT Margin -155.15%
FCF Margin n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.31%
Shareholder Yield -1.31%
Earnings Yield -28.79%
FCF Yield -24.51%
Dividend Details

Analyst Forecast

The average price target for Moderna is $33.91, which is 22.42% higher than the current price. The consensus rating is "Hold".

Price Target $33.91
Price Target Difference 22.42%
Analyst Consensus Hold
Analyst Count 13
Revenue Growth Forecast (5Y) 16.84%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Moderna has an Altman Z-Score of 3.5 and a Piotroski F-Score of 1.

Altman Z-Score 3.5
Piotroski F-Score 1